NCT02465957 - QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 24, 2015

Primary Completion Date

March 19, 2018

Study Completion Date

March 19, 2018

Conditions

Stage IIIB Merkel Cell CarcinomaStage IV Merkel Cell Carcinoma

Interventions

BIOLOGICAL

aNK (NK-92)

A natural killer cell line recovered from a patient with large granular lymphoma

BIOLOGICAL

aNK (NK-92) + N-803

aNK - A natural killer cell line recovered from a patient with large granular lymphoma and N-803 - Recombinant human super agonist interleukin-15 (IL-15) complex

Trial Locations (3)

15232

UPMC Cancer Center, Pittsburgh

60611

Robert H. Lurie Comprehensive Cancer Center, Chicago

98109

Seattle Cancer Care Alliance, Seattle